middle.news
ResMed Sells MatrixCare for $490 Million to Sharpen Focus on Sleep Tech
8:24am on Wednesday 8th of July, 2026 AEST
•
Healthcare Technology
Read Story
ResMed Sells MatrixCare for $490 Million to Sharpen Focus on Sleep Tech
8:24am on Wednesday 8th of July, 2026 AEST
Key Points
MatrixCare sold for $490 million cash
Sale aligns with ResMed's 2030 strategic focus
MatrixCare generated $220 million revenue in FY26
Proceeds earmarked for share buybacks and corporate use
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Resmed (ASX:RMD)
OPEN ARTICLE